The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer-Reference-Cited by-同舟云学术

The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer

Published:2017-06-17 Issue:53 Volume:8 Page:90897-90904
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wan Jiayi¹,Yin Yongxiang²,Zhao Min²,Shen Fang³,Chen Miaoxin⁴,Chen Qi³⁵

Affiliation:

1. Department of Pathology, Wuxi No2 People’s Hospital, Nanjing Medical University, Wuxi, China

2. Department of Pathology, Wuxi Maternity and Children Hospital, Nanjing Medical University, Wuxi, China

3. The Hospital of Obstetrics and Gynaecology, Fudan University, Shanghai, China

4. Centre for Reproductive Medicine, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China

5. Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Body Size: Adiponectin as a Key Player in Obesity-Driven Cancers;Nutrition and Cancer;2023-10-24

2. Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer;Cancers;2023-05-20

3. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer;International Immunopharmacology;2022-07

4. Role of Leptin and Adiponectin in Endometrial Cancer;International Journal of Molecular Sciences;2022-05-10

5. Adjuvant effects of chemotherapeutics and Metformin on MFE-319 endometrial carcinoma cell line;Romanian Journal of Morphology and Embryology;2021-04-01